Gaviscon Advance Chewable Tablets
*Company:
Reckitt Benckiser Ireland LimitedStatus:
No Recent UpdateLegal Category:
Supply through pharmacy onlyActive Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 16 September 2024
File name
Gav Advance Tabs SmPC Feb23.pdf
Reasons for updating
- Change to section 1 - Name of medicinal product
Legal category:Supply through pharmacy only
Updated on 16 September 2024
File name
Gaviscon Advance Tablets PIL Feb23.pdf
Reasons for updating
- Change to name of medicinal product
Updated on 11 April 2022
File name
Gavi Advance Tabs SmPC.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 4.9 - Overdose
- Change to section 6.1 - List of excipients
Legal category:Supply through pharmacy only
Updated on 14 October 2020
File name
Gaviscon Advance Chewable Tablets PIL July 20.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 20 August 2020
File name
Gaviscon Advance Chewable Tablets July20.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Supply through pharmacy only
Updated on 15 January 2020
File name
Gaviscon Advance Tablets.pdf
Reasons for updating
- Change to section 6 - manufacturer
Updated on 21 July 2015
Reasons for updating
- New SPC for new product
Legal category:Supply through pharmacy only
Updated on 21 July 2015
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.7 - Effects on ability to drive and use machines
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 4.2 - Posology and method of administration
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Updated on 20 July 2015
File name
PIL_16414_873.pdf
Reasons for updating
- New PIL for new product
Updated on 14 December 2012
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Excipient with known effect: Aspartame (E951) 4.5mg in 1 tablet.
Updated on 15 November 2011
Reasons for updating
- Change to section 10 - Date of revision of the text
- Change to section 9 - Date of renewal of authorisation
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
Included the date of last renewal: 05th January 2010
10. DATE OF REVISION OF THE TEXT
amended to November 2011
Updated on 15 May 2007
Reasons for updating
- Change to section 4.1 - Therapeutic indications
- Change to section 4.6 - Pregnancy and lactation
- Change to section 6.1 - List of excipients
- Change to section 6.5 - Nature and contents of container
- Change to section 7 - Marketing authorisation holder
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Updated on 04 August 2006
Reasons for updating
- New SPC for new product
Legal category:Supply through pharmacy only